Vanguard AG - Medical Remanufacturing
Dr. Marc Schulte is a highly qualified professional in the field of microbiology and laboratory management, currently serving as the Head of Laboratory and Hygiene Conception at Vanguard AG since July 2021. Responsibilities include overseeing a testing laboratory adhering to DIN EN ISO/IEC 17025 standards, managing laboratory staff, and optimizing test methods. Prior experience includes roles as a Postdoctoral Researcher and Associate Researcher at Universität Osnabrück's CellNanOs - Center for Cellular Nanoanalytics, focusing on bacterial pathogens and advanced microscopy techniques. Dr. Schulte holds a Doctorate in Microbiology from Universität Osnabrück, along with a Master of Science and Bachelor of Science in Biosciences. Additionally, qualifications include ISO 9000 quality management and specialized training in laboratory management.
This person is not in any teams
Vanguard AG - Medical Remanufacturing
Vanguard is a Berlin-based medical remanufacturer. Since 1998, Vanguard has pursued the goal of advancing and strengthening the circular economy within the medical technology and healthcare sector. For over 20 years, Vanguard has set the global standard for medical remanufacturing, empowering healthcare institutions to operate more sustainably and in a future-oriented manner. Offering sophisticated and environmentally-friendly product solutions made in Germany, Vanguard uses innovative and certified medical remanufacturing processes. With its advanced technology, superior quality and expertise, Vanguard has established itself as a market leader in Europe, specialising in the remanufacturing of cooled ablation catheters and catheters with 3D mapping systems.